JokerForever
2021-11-23
What going on here??
iSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen 股价早盘飙升超过 140%</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":875111826,"tweetId":"875111826","gmtCreate":1637624276701,"gmtModify":1637624276856,"author":{"id":4089081450453300,"idStr":"4089081450453300","authorId":4089081450453300,"authorIdStr":"4089081450453300","name":"JokerForever","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":21,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>What going on here?? </p></body></html>","htmlText":"<html><head></head><body><p>What going on here?? </p></body></html>","text":"What going on here??","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/875111826","repostId":1121185868,"repostType":4,"repost":{"id":"1121185868","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637592275,"share":"https://www.laohunote.com/m/news/1121185868?lang=zh_CN&edition=full","pubTime":"2021-11-22 22:44","market":"us","language":"en","title":"iSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen 股价早盘飙升超过 140%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1121185868","media":"Tiger Newspress","summary":"iSpecimen shares surged more than 140% in early trading.iSpecimen Inc.(Nasdaq: ISPC), an online mark","content":"<p>iSpecimen shares surged more than 140% in early trading.<img src=\"https://static.tigerbbs.com/004231075c27a5023d82afda7d30605e\" tg-width=\"865\" tg-height=\"597\" width=\"100%\" height=\"auto\"><b><a href=\"https://laohu8.com/S/ISPC\">iSpecimen Inc.</a></b>(Nasdaq: ISPC), an online marketplace for<u>human biospecimens</u>, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.</p><p><blockquote>iSpecimen 股价早盘飙升超过 140%。<b><a href=\"https://laohu8.com/S/ISPC\">样本公司。</a></b>（纳斯达克：ISPC），一个在线市场<u>人体生物标本</u>今天宣布，它已签约支持关于新冠肺炎的新的先进研究，以寻求对其在多个人群中的传播性、变异、结果和测试有效性的见解。在过去的十个月里，该公司与多个研究和医疗保健组织合作开展了一系列需要各种新冠肺炎样本的不同项目，包括鼻拭子、唾液和血液制品。</blockquote></p><p> The Company's work on COVID-19 began immediately after the outbreak last year when it began sending serum samples to the U.S. Centers for Disease Control and Prevention to help researchers monitor antibody development for possible guidance on immunity. iSpecimen provided the Centers for Disease Control and Prevention (\"CDC\") with 600 SARS-CoV-2-positive serum samples and 100 negative serum samples, mostly remnants from lab tests.</p><p><blockquote>该公司在 COVID-19 方面的工作在去年疫情爆发后立即开始，当时它开始向美国疾病控制和预防中心发送血清样本，以帮助研究人员监测抗体的发展，以获得可能的免疫指导。iSpecimen向疾病控制和预防中心（“CDC”）提供了600份新型冠状病毒阳性血清样本和100份阴性血清样本，大部分是实验室测试的残留物。</blockquote></p><p> In addition, iSpecimen has been contracted by other federal agencies and private companies for custom COVID-19 collections, which are often complex and complement the more immediate availability of remnant or banked samples.</p><p><blockquote>此外，iSpecimen 还与其他联邦机构和私营公司签约进行定制 COVID-19 采集，这些采集通常很复杂，并补充了更即时可用的剩余或存储样本。</blockquote></p><p> \"COVID-19 has claimed more than 5 million lives, and it will require a lot of additional research to control the pandemic and improve society's ability to contend with future outbreaks of infectious diseases,\" said iSpecimen Founder and CEO,Christopher Ianelli, MD, Ph.D. \"We embrace the challenge and are gratified that researchers are coming to us for the specific biospecimens they need from the types of patients they're focusing on.\"</p><p><blockquote>iSpecimen 创始人兼首席执行官 Christopher Ianelli 医学博士表示：“COVID-19 已夺去了超过 500 万人的生命，需要进行大量额外的研究来控制这一流行病并提高社会应对未来传染病爆发的能力。”“我们接受这一挑战，并很高兴研究人员向我们寻求他们所关注的患者类型所需的特定生物标本。”</blockquote></p><p> <b>COVID-Related Research</b></p><p><blockquote><b>COVID相关研究</b></blockquote></p><p> In addition to the work iSpecimen has done with the CDC, iSpecimen has recently supplied hundreds of human biospecimens to ongoing COVID-19 research being conducted by the United Statesmilitary. The specimens, including positive SARS-CoV-2 samples and negative controls, help researchers validate COVID-19 testing platforms, understand fluctuations in patients' antibody levels, monitor contagion among close contacts, and more.</p><p><blockquote>除了 iSpecimen 与 CDC 合作的工作外，iSpecimen 最近还为美国军方正在进行的 COVID-19 研究提供了数百个人类生物标本。这些样本，包括阳性新型冠状病毒样本和阴性对照，有助于研究人员验证新冠肺炎检测平台，了解患者抗体水平的波动，监测密切接触者之间的传染病等。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen 股价早盘飙升超过 140%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niSpecimen shares surged more than 140% in early trading<blockquote>iSpecimen 股价早盘飙升超过 140%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-22 22:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>iSpecimen shares surged more than 140% in early trading.<img src=\"https://static.tigerbbs.com/004231075c27a5023d82afda7d30605e\" tg-width=\"865\" tg-height=\"597\" width=\"100%\" height=\"auto\"><b><a href=\"https://laohu8.com/S/ISPC\">iSpecimen Inc.</a></b>(Nasdaq: ISPC), an online marketplace for<u>human biospecimens</u>, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.</p><p><blockquote>iSpecimen 股价早盘飙升超过 140%。<b><a href=\"https://laohu8.com/S/ISPC\">样本公司。</a></b>（纳斯达克：ISPC），一个在线市场<u>人体生物标本</u>今天宣布，它已签约支持关于新冠肺炎的新的先进研究，以寻求对其在多个人群中的传播性、变异、结果和测试有效性的见解。在过去的十个月里，该公司与多个研究和医疗保健组织合作开展了一系列需要各种新冠肺炎样本的不同项目，包括鼻拭子、唾液和血液制品。</blockquote></p><p> The Company's work on COVID-19 began immediately after the outbreak last year when it began sending serum samples to the U.S. Centers for Disease Control and Prevention to help researchers monitor antibody development for possible guidance on immunity. iSpecimen provided the Centers for Disease Control and Prevention (\"CDC\") with 600 SARS-CoV-2-positive serum samples and 100 negative serum samples, mostly remnants from lab tests.</p><p><blockquote>该公司在 COVID-19 方面的工作在去年疫情爆发后立即开始，当时它开始向美国疾病控制和预防中心发送血清样本，以帮助研究人员监测抗体的发展，以获得可能的免疫指导。iSpecimen向疾病控制和预防中心（“CDC”）提供了600份新型冠状病毒阳性血清样本和100份阴性血清样本，大部分是实验室测试的残留物。</blockquote></p><p> In addition, iSpecimen has been contracted by other federal agencies and private companies for custom COVID-19 collections, which are often complex and complement the more immediate availability of remnant or banked samples.</p><p><blockquote>此外，iSpecimen 还与其他联邦机构和私营公司签约进行定制 COVID-19 采集，这些采集通常很复杂，并补充了更即时可用的剩余或存储样本。</blockquote></p><p> \"COVID-19 has claimed more than 5 million lives, and it will require a lot of additional research to control the pandemic and improve society's ability to contend with future outbreaks of infectious diseases,\" said iSpecimen Founder and CEO,Christopher Ianelli, MD, Ph.D. \"We embrace the challenge and are gratified that researchers are coming to us for the specific biospecimens they need from the types of patients they're focusing on.\"</p><p><blockquote>iSpecimen 创始人兼首席执行官 Christopher Ianelli 医学博士表示：“COVID-19 已夺去了超过 500 万人的生命，需要进行大量额外的研究来控制这一流行病并提高社会应对未来传染病爆发的能力。”“我们接受这一挑战，并很高兴研究人员向我们寻求他们所关注的患者类型所需的特定生物标本。”</blockquote></p><p> <b>COVID-Related Research</b></p><p><blockquote><b>COVID相关研究</b></blockquote></p><p> In addition to the work iSpecimen has done with the CDC, iSpecimen has recently supplied hundreds of human biospecimens to ongoing COVID-19 research being conducted by the United Statesmilitary. The specimens, including positive SARS-CoV-2 samples and negative controls, help researchers validate COVID-19 testing platforms, understand fluctuations in patients' antibody levels, monitor contagion among close contacts, and more.</p><p><blockquote>除了 iSpecimen 与 CDC 合作的工作外，iSpecimen 最近还为美国军方正在进行的 COVID-19 研究提供了数百个人类生物标本。这些样本，包括阳性新型冠状病毒样本和阴性对照，有助于研究人员验证新冠肺炎检测平台，了解患者抗体水平的波动，监测密切接触者之间的传染病等。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISPC":"iSpecimen Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121185868","content_text":"iSpecimen shares surged more than 140% in early trading.iSpecimen Inc.(Nasdaq: ISPC), an online marketplace forhuman biospecimens, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.\nThe Company's work on COVID-19 began immediately after the outbreak last year when it began sending serum samples to the U.S. Centers for Disease Control and Prevention to help researchers monitor antibody development for possible guidance on immunity. iSpecimen provided the Centers for Disease Control and Prevention (\"CDC\") with 600 SARS-CoV-2-positive serum samples and 100 negative serum samples, mostly remnants from lab tests.\nIn addition, iSpecimen has been contracted by other federal agencies and private companies for custom COVID-19 collections, which are often complex and complement the more immediate availability of remnant or banked samples.\n\"COVID-19 has claimed more than 5 million lives, and it will require a lot of additional research to control the pandemic and improve society's ability to contend with future outbreaks of infectious diseases,\" said iSpecimen Founder and CEO,Christopher Ianelli, MD, Ph.D. \"We embrace the challenge and are gratified that researchers are coming to us for the specific biospecimens they need from the types of patients they're focusing on.\"\nCOVID-Related Research\nIn addition to the work iSpecimen has done with the CDC, iSpecimen has recently supplied hundreds of human biospecimens to ongoing COVID-19 research being conducted by the United Statesmilitary. The specimens, including positive SARS-CoV-2 samples and negative controls, help researchers validate COVID-19 testing platforms, understand fluctuations in patients' antibody levels, monitor contagion among close contacts, and more.","news_type":1,"symbols_score_info":{"ISPC":0.9}},"isVote":1,"tweetType":1,"viewCount":4591,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/875111826"}
精彩评论